C4 Therapeutics, Inc.
USD4.53
+0.18 (+4.14%)
CEO
Andrew J. Hirsch
IPO Date
2020-10-02
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.35
Prev. Close
$4.35
Day Low
$4.33
Day High
$4.76
52W Low
$1.40
52W High
$4.76
Market Cap
$0.38B
Volume
1.42M
| 62,000 |
| $4.25 |
| 26 Jun 2026 | Koppikar Utpal | director | A-Award | Acquired | 62,000 | $4.25 |
| 26 Jun 2026 | Anderson Kenneth Carl | director | A-Award | Acquired | 62,000 | $4.25 |
| 26 Jun 2026 | Cooper Ronald Harold Wilfred | director | A-Award | Acquired | 62,000 | $4.25 |
| 26 Jun 2026 | Bessen Laura | director | A-Award | Acquired | 62,000 | $4.25 |
| 26 Jun 2026 | Fawell Stephen | director | A-Award | Acquired | 62,000 | $4.25 |
| 26 Jun 2026 | GROGAN DONNA ROY | director | A-Award | Acquired | 62,000 | $4.25 |
| 4 Jun 2026 | Anderson Kenneth Carl | director | M-Exempt | Acquired | 1,070 | $2.11 |
| 4 Jun 2026 | Anderson Kenneth Carl | director | M-Exempt | Disposed | 1,070 | $2.11 |